The classes of antiretroviral therapy drugs attack the HIV virus at various points in the duplication process to prevent it from making copies of itself. Taking an ART cocktail of drugs from ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with HIV without preliminary drug resistance testing in a phase 4 trial.

People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

Many treatments can help people with HIV live longer, more fulfilling lives. The main treatment for HIV is antiretroviral medication. Every year, researchers are investigating new therapies in the ...

Pre-exposure prophylaxis, or PrEP, is part of the daily routine for a growing number of Canadians at risk of exposure to HIV through sex or injection drugs. While most people take it in pill ...

But only 3.5 million take pre-exposure prophylaxis (PrEP), which reduces a person’s risk of getting HIV. Researchers believe that giving people the option for long-lasting treatment could help ...